Daidzein and 17β-estradiol enhance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 2, 2004, Pages 155-163

  Woodman, Owen L ^a   Missen, Melinda A ^a   Boujaoude, Mirna ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Arteries; Endothelial function; Estrogen; Isoflavone; Nitric oxide; Vasodilatation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; CALMODULIN; CAVEOLIN 1; CYCLIC GMP; DAIDZEIN; DRUG VEHICLE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; FULVESTRANT; ISOFLAVONE DERIVATIVE; ISOPRENALINE; NITROPRUSSIDE SODIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; VASCULAR RING; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA; BODY WEIGHT; CALMODULIN; CAVEOLIN 1; CAVEOLINS; CYCLIC GMP; DRUG SYNERGISM; ENDOTHELIUM, VASCULAR; ESTRADIOL; GENE EXPRESSION; INJECTIONS, SUBCUTANEOUS; ISOFLAVONES; ISOPROTERENOL; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; NITROARGININE; NITROPRUSSIDE; ORGAN SIZE; PHENOXYBENZAMINE; RATS; RATS, SPRAGUE-DAWLEY; TESTIS;

EID: 3242779349     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200408000-00003     Document Type: Article

References (39)

1. Kauser K, Rubanyi GM. Potential cellular signaling mechanisms mediating upregulation of endothelial nitric oxide production by estrogen. J Vasc Res. 1997;34:229-236.
2. Fulton D, Gratton JP, Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J Pharmacol Exp Ther. 2001;299:818-824.
3. Pelligrino DA, Ye S, Tan F, et al. Nitric-oxide-dependent pial arteriolar dilation in the female rat: effects of chronic estrogen depletion and repletion. Biochem Biophys Res Commun. 2000;269:165-171.
4. Xu HL, Galea E, Santizo RA, et al. The key role of caveolin-1 in estrogen-mediated regulation of endothelial nitric oxide synthase function in cerebral arterioles in vivo. J Cereb Blood Flow Metab. 2001;21:907-913.
5. McNeill AM, Zhang C, Stanczyk FZ, et al. Estrogen increases endothelial nitric oxide synthase via estrogen receptors in rat cerebral blood vessels: effect preserved after concurrent treatment with medroxyprogesterone acetate or progesterone. Stroke. 2002;33:1685-1691.
6. Tamura K, Yamaguchi K, Kogo H. 17 Beta-estradiol inhibits ovariectomy-induced expression of inducible nitric oxide synthase in rat aorta in vivo. Life Sci. 2000;66:PL259-PL264.
7. Barbacanne MA, Rami J, Michel JB, et al. Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: possible role of decreased endothelium-derived superoxide anion production. Cardiovasc Res. 1999;41:672-681.
8. Darblade B, Pendaries C, Krust A, et al. Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor. Circ Res. 2002;90:413-419.
9. Wang X, Abdel-Rahman AA. Estrogen modulation of eNOS activity and its association with caveolin-3 and calmodulin in rat hearts. Am J Physiol Heart Circ Physiol. 2002;282:H2309-H2315.
10. Govers R, Rabelink TJ. Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol. 2001;280:F193-F206.
11. Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet. 2002;360:942-944.
12. Grady D, Herrington D, Bitmer V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002;288:49-57.
13. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998;280:605-613.
14. WHI Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health initiative randomized controlled trial. JAMA. 2002;288:321-333.
15. Anthony MS, Clarkson TB, Hughes CL, et al. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr. 1996;126:43-50.
16. Mitchell JH, Cawood E, Kinniburgh D, et al. Effect of a phytoestrogen food supplement on reproductive health in normal males. Clin Sci. 2001; 100:613-618.
17. Squadrito F, Altavila D, Squadrito G, et al. Genistein supplementation and estrogen replacement therapy improve endothelial dysfunction induced by ovariectomy in rats. Cardiovasc Res. 2000;45:454-462.
18. New G, Duffy SJ, Harper RW, et al. Estrogen improves acetylcholine- induced but not metabolic vasodilation in biological males. Am J Physiol. 1999;277:H2341-H2347.
19. Anderson HL, Weis JU, Fjalland B, et al. Effect of acute and long-term treatment with 17β-estradiol on the vasomotor responses in the rat aorta. Br J Pharmacol. 1999;126:159-168.
20. Woodman OL, Boujaoude M. Chronic treatment of male rats with daidzein and 17β-estradiol induces the contribution of EDHF to endothelium-dependent relaxation. Br J Pharmacol. 2004;141:322-328.
21. Martin GR, Bolofo ML, Giles H. Inhibition of endothelium-dependent vasorelaxation by arginine analogues: a pharmacological analysis of agonist and tissue dependence. Br J Pharmacol. 1992;105:643-652.
22. Johnson DC, Banerjee S, Chatterjee S. Estradiol and chlordecone (kepone) decrease adenosine 3′5′-cyclic monophosphate concentrations in the ovariectomized immature rat uterus. Proc Soc Exp Biol Med. 1995;210:33-38.
23. Giovannoni G, Land JM, Keir G, et al. Adaptation of the nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels. Ann Clin Biochem. 1997;34:193-198.
24. Caulin-Glaser T, Garcia-Cardena G, Sarrel P, et al. 17 β-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization. Circ Res. 1997;81:885-892.
25. Goetz RM, Thatte HS, Prabhakar P, et al. Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 1999;96:2788-2793.
26. MacRitchie AN, Jun SS, Chen Z, et al. Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ Res. 1997;81:355-362.
27. Beyer ME, Yu G, Hanke H, et al. Acute gender-specific hemodynamic and inotropic effects of 17beta-estradiol on rats. Hypertension. 2001;38: 1003-1010.
28. Shaw L, Taggart MJ, Austin C. Mechanisms of 17 beta-oestradiol induced vasodilatation in isolated pressurized rat small arteries. Br J Pharmacol. 2000;129:555-565.
29. 2+ entry inhibition. J Cereb Blood Flow Metab. 2001;21:422-429.
30. Iafrati MD, Karas RH, Aronovitz M, et al. Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice. Nat Med. 1997;3: 545-548.
31. Geary GG, McNeill AM, Ospina JA, et al. Cerebrovascular NOS and cyclooxygenase are unaffected by estrogen in mice lacking estrogen receptor-alpha. J Appl Physiol. 2001;91:2391-2399.
32. Muller-Delp JM, Lubahn DB, Nichol KE, et al. Regulation of nitric oxide-dependent vasodilation in coronary arteries of estrogen receptor-{alpha}-deficient mice. Am J Physiol Heart Circ Physiol. 2003;285:H2150-H2157.
33. Wang D, Gutkowska J, Marcinkiewicz M, et al. Genistein supplementation stimulates the oxytocin system in the aorta of ovariectomized rats. Cardiovasc Res. 2003;57:186-194.
34. Zhai P, Eurell TE, Cotthaus RP, et al. Effects of dietary phytoestrogen on global myocardial ischemia-reperfusion injury in isolated female rat hearts. Am J Physiol Heart Circ Physiol. 2001;281:H1223-H1232.
35. Liew R, Williams JK, Collins P, et al. Soy-derived isoflavones exert opposing actions on Guinea pig ventricular myocytes. J Pharmacol Exp Ther. 2003;304:985-993.
36. Xu L, Carter EP, Ohara M, et al. Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis. Am J Physiol Renal Physiol. 2000;279:F1110-F1115.
37. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340:1801-1811.
38. Nestel P. Isoflavones: their effects on cardiovascular risk and functions. Curr Opin Lipidol. 2003;14:3-8.
39. Arnal JF, Clamens S, Pechet C, et al. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci USA. 1996;93:4108-4113.